Betta Pharmaceuticals Co., Ltd. (300558.SZ)
CNY 54.71
(0.66%)
CNY 54.71
(0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.45 Billion | 2.37 Billion | 2.24 Billion | 1.87 Billion | 1.55 Billion | 1.22 Billion |
| Cost of Revenue | 404.48 Million | 268.69 Million | 174.43 Million | 138.89 Million | 105.22 Million | 68.98 Million |
| Gross Profit | 2.05 Billion | 2.1 Billion | 2.07 Billion | 1.73 Billion | 1.44 Billion | 1.15 Billion |
| Operating Expenses | 1.78 Billion | 1.89 Billion | 1.68 Billion | 1.28 Billion | 1.13 Billion | 960.86 Million |
| Selling, General and Administrative Expenses | 1.12 Billion | 1.09 Billion | 1 Billion | 819.65 Million | 701.03 Million | 596.15 Million |
| Research and Development Expenses | 640.13 Million | 699.9 Million | 565.94 Million | 362.85 Million | 326.36 Million | 303.69 Million |
| Other Expenses | 20.53 Million | 103.8 Million | 116.36 Million | 106.3 Million | 109.54 Million | 1.66 Million |
| Cost and Expenses | 2.18 Billion | 2.16 Billion | 1.86 Billion | 1.42 Billion | 1.24 Billion | 1.02 Billion |
| Operating Income | 270.06 Million | 201.78 Million | 395.6 Million | 680.66 Million | 266.56 Million | 180.7 Million |
| Interest Expense | 54.95 Million | 195.8 Million | 15.77 Million | 39.85 Million | 48.05 Million | 25.18 Million |
| Income Tax Expense | -11.54 Million | -37.19 Million | 10.36 Million | 65.57 Million | 40.61 Million | 18.85 Million |
| Earnings before Tax | 322.07 Million | 87.57 Million | 389.92 Million | 666.66 Million | 266.45 Million | 182.37 Million |
| Net Income | 348.03 Million | 145.42 Million | 383.06 Million | 606.36 Million | 230.82 Million | 166.81 Million |
| Earnings Per Share Basic | 0.83 | 0.35 | 0.92 | 1.50 | 0.58 | 0.42 |
| Earnings Per Share Diluted | 0.83 | 0.35 | 0.92 | 1.49 | 0.57 | 0.42 |
| Weighted Average Shares Outstanding | 419.31 Million | 415.48 Million | 415.38 Million | 404.24 Million | 401 Million | 397.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 419.31 Million | 415.48 Million | 415.38 Million | 406.95 Million | 404.95 Million | 397.18 Million |
| Gross Margin | 0.84 | 0.89 | 0.92 | 0.93 | 0.93 | 0.94 |
| EBIT Margin | 0.28 | 0.19 | 0.26 | 0.47 | 0.29 | 0.25 |
| Profit Margin | 0.14 | 0.06 | 0.17 | 0.32 | 0.15 | 0.14 |
| EBITDA | 696.09 Million | 455.48 Million | 580.88 Million | 862.85 Million | 457.27 Million | 309.83 Million |
| Earnings Before Tax Margin | 0.11 | 0.08 | 0.18 | 0.36 | 0.17 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 838.75 Million | 760.24 Million | 730.66 Million | 412.38 Million | 2.44 Billion | 729.67 Million |
| Cost of Revenue | 137.41 Million | 154.74 Million | 128.54 Million | 152.58 Million | 565.61 Million | 85.69 Million |
| Gross Profit | 701.34 Million | 605.49 Million | 602.12 Million | 259.79 Million | 1.87 Billion | 643.97 Million |
| Operating Expenses | 557.9 Million | 450.38 Million | 492.88 Million | 245.64 Million | 1.59 Billion | 472.02 Million |
| Selling, General and Administrative Expenses | 430.14 Million | 360.73 Million | 340.13 Million | 86.91 Million | - | 413.95 Million |
| Research and Development Expenses | 127.75 Million | 89.65 Million | 152.75 Million | 158.72 Million | - | 133.42 Million |
| Other Expenses | - | -2.67 Million | -1.13 Million | -2.75 Million | 1.79 Million | -1 Million |
| Cost and Expenses | 695.31 Million | 605.13 Million | 621.42 Million | 398.23 Million | 2.16 Billion | 557.72 Million |
| Operating Income | 143.43 Million | 155.11 Million | 109.23 Million | 14.15 Million | 279.57 Million | 150.58 Million |
| Interest Expense | 9.26 Million | 11.26 Million | 11 Million | 12.76 Million | 54.95 Million | 12.18 Million |
| Income Tax Expense | -7.28 Million | 20.52 Million | 13.43 Million | -9.2 Million | -11.54 Million | -2.96 Million |
| Earnings before Tax | 183.45 Million | 145.88 Million | 109.37 Million | 29.59 Million | 336.06 Million | 149.57 Million |
| Net Income | 192.27 Million | 125.8 Million | 98.14 Million | 43.33 Million | 348.03 Million | 156.38 Million |
| Earnings Per Share Basic | 0.46 | 0.30 | 0.23 | 0.10 | - | 0.37 |
| Earnings Per Share Diluted | 0.46 | 0.30 | 0.23 | 0.10 | - | 0.37 |
| Weighted Average Shares Outstanding | 418.48 Million | 418.48 Million | 418.48 Million | 418.48 Million | 418.48 Million | 418.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 418.48 Million | 418.48 Million | 418.48 Million | 418.48 Million | 418.48 Million | 418.48 Million |
| Gross Margin | 0.84 | 0.80 | 0.82 | 0.63 | 0.77 | 0.88 |
| EBIT Margin | 0.23 | 0.31 | 0.16 | 0.23 | - | 0.23 |
| Profit Margin | 0.23 | 0.17 | 0.13 | 0.11 | 0.14 | 0.21 |
| EBITDA | 192.72 Million | 239 Million | 114.93 Million | 95.47 Million | - | 167.91 Million |
| Earnings Before Tax Margin | 0.17 | 0.20 | 0.15 | 0.03 | 0.11 | 0.21 |
ABI
BNRE
HAZOOR
LAOPALA
0HVF
PRIC-B